Navigating trial design in radiation dermatitis research: paths to improvement.
作者信息
Dejonckheere Cas Stefaan, Schmeel Leonard Christopher
机构信息
Department of Radiation Oncology, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
出版信息
Support Care Cancer. 2024 Oct 29;32(11):754. doi: 10.1007/s00520-024-08959-5.
Abstract
摘要
相似文献
1
Navigating trial design in radiation dermatitis research: paths to improvement.辐射性皮炎研究中的试验设计导航：改进之路
Support Care Cancer. 2024 Oct 29;32(11):754. doi: 10.1007/s00520-024-08959-5.
2
Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trial.局部皮质类固醇与安慰剂预防头颈部癌症患者接受放化疗后放射性皮炎的比较：J-SUPPORT 1602（TOPICS 研究）的研究方案，一项随机、双盲、3 期临床试验。
BMC Cancer. 2018 Sep 6;18(1):873. doi: 10.1186/s12885-018-4763-1.
3
Gel of chamomile vs. urea cream to prevent acute radiation dermatitis in patients with head and neck cancer: a randomized controlled trial.洋甘菊凝胶与尿素乳膏预防头颈癌患者急性放射性皮炎的随机对照试验
J Adv Nurs. 2016 Aug;72(8):1926-34. doi: 10.1111/jan.12955. Epub 2016 Mar 29.
4
The effect of recombinant human epidermal growth factor on radiation dermatitis in rectal and anal cancer patients: a self-controlled study.重组人表皮生长因子对直肠癌和肛门癌患者放射性皮炎的影响：一项自身对照研究。
BMC Cancer. 2022 Nov 5;22(1):1140. doi: 10.1186/s12885-022-10226-x.
5
A blinded-endpoint, randomized controlled trial of Sanyrene with natural active ingredient for prophylaxis of radiation dermatitis in patients receiving radiotherapy.一项以 Sanyrene 天然活性成分为主的预防放疗患者放射性皮炎的盲终点、随机对照试验。
Radiat Oncol. 2023 Oct 27;18(1):174. doi: 10.1186/s13014-023-02363-9.
6
Radiotherapy-related skin toxicity (RAREST-02): A randomized trial testing the effect of a mobile application reminding head-and-neck cancer patients to perform skin care (reminder app) on radiation dermatitis.放疗相关性皮肤毒性（RAREST-02）：一项随机试验，旨在测试提醒头颈部癌症患者进行皮肤护理的移动应用（提醒应用程序）对放射性皮炎的影响。
Trials. 2020 May 25;21(1):424. doi: 10.1186/s13063-020-04307-0.
7
Feasibility and Tolerability of Adjuvant Capecitabine-Based Chemoradiation in Patients With Breast Cancer and Residual Disease After Neoadjuvant Chemotherapy: A Prospective Clinical Trial.辅助卡培他滨同步放化疗用于新辅助化疗后有残留病灶的乳腺癌患者的可行性和耐受性：一项前瞻性临床试验
Int J Radiat Oncol Biol Phys. 2024 Apr 1;118(5):1262-1270. doi: 10.1016/j.ijrobp.2023.06.076. Epub 2023 Jul 16.
8
Radiotherapy related skin toxicity (RAREST-01): Mepitel® film versus standard care in patients with locally advanced head-and-neck cancer.放疗相关皮肤毒性（RAREST-01）：局部晚期头颈部癌患者的 Mepitel®薄膜与标准护理的比较。
BMC Cancer. 2018 Feb 17;18(1):197. doi: 10.1186/s12885-018-4119-x.
9
Quality-of-life outcomes following topical melatonin application against acute radiation dermatitis in patients with early breast cancer: A double-blind, randomized, placebo-controlled trial.局部应用褪黑素治疗早期乳腺癌急性放射性皮炎对生活质量的影响：一项双盲、随机、安慰剂对照试验。
J Pineal Res. 2023 Jan;74(1):e12840. doi: 10.1111/jpi.12840. Epub 2022 Nov 24.
10
Phase 3 Randomized Trial of Topical Steroid Versus Placebo for Prevention of Radiation Dermatitis in Patients With Head and Neck Cancer Receiving Chemoradiation.头颈部癌症患者接受放化疗时，预防放射性皮炎的局部皮质类固醇与安慰剂的 3 期随机试验。
Int J Radiat Oncol Biol Phys. 2021 Nov 1;111(3):794-803. doi: 10.1016/j.ijrobp.2021.05.133. Epub 2021 Jun 6.
引用本文的文献
1
for the Management of Radiation-Induced Cerebral Edema and Necrosis: A Systematic Meta-Narrative Review of Clinical Evidence.辐射诱导性脑水肿和坏死的管理：临床证据的系统元叙事综述
Adv Radiat Oncol. 2025 Feb 1;10(4):101732. doi: 10.1016/j.adro.2025.101732. eCollection 2025 Apr.
本文引用的文献
1
Pharmaceutical management of acute radiation dermatitis in the German speaking radiation oncology community.德语放疗领域中急性放射性皮炎的药物治疗管理。
J Dtsch Dermatol Ges. 2024 Feb;22(2):198-207. doi: 10.1111/ddg.15279. Epub 2023 Dec 13.
2
Safety and efficacy of helical tomotherapy following lung-sparing surgery in locally advanced malignant pleural mesothelioma.螺旋断层放疗联合同步化疗保肺手术治疗局部晚期恶性胸膜间皮瘤的安全性和有效性。
Strahlenther Onkol. 2024 Jul;200(7):605-613. doi: 10.1007/s00066-023-02174-7. Epub 2023 Nov 22.
3
Risk assessment, surveillance, and nonpharmaceutical prevention of acute radiation dermatitis: results of a multicentric survey among the German-speaking radiation oncology community.急性放射性皮炎的风险评估、监测和非药物预防：德语放疗界的一项多中心调查结果。
Strahlenther Onkol. 2023 Oct;199(10):891-900. doi: 10.1007/s00066-023-02074-w. Epub 2023 Apr 26.
4
Multinational Association of Supportive Care in Cancer (MASCC) clinical practice guidelines for the prevention and management of acute radiation dermatitis: international Delphi consensus-based recommendations.癌症支持性护理多国协会（MASCC）急性放射性皮炎预防与管理临床实践指南：基于国际德尔菲共识的建议
Lancet Oncol. 2023 Apr;24(4):e172-e185. doi: 10.1016/S1470-2045(23)00067-0.
5
Current quality of life assessment tools may not fully address dermatological adverse events from anti-cancer therapies.当前的生活质量评估工具可能无法充分解决癌症治疗相关的皮肤不良反应。
Support Care Cancer. 2022 Dec;30(12):9681-9685. doi: 10.1007/s00520-022-07424-5. Epub 2022 Oct 24.
6
Effect of Supine vs Prone Breast Radiotherapy on Acute Toxic Effects of the Skin Among Women With Large Breast Size: A Randomized Clinical Trial.仰卧位与俯卧位乳腺放疗对大乳房女性皮肤急性毒性反应的影响：一项随机临床试验
JAMA Oncol. 2022 Jul 1;8(7):994-1000. doi: 10.1001/jamaoncol.2022.1479.
7
Comparison of clinical practice guidelines on radiation dermatitis: a narrative review.比较辐射性皮炎临床实践指南：叙述性综述。
Support Care Cancer. 2022 Jun;30(6):4663-4674. doi: 10.1007/s00520-022-06829-6. Epub 2022 Jan 24.
8
Predictive factors associated with radiation dermatitis in breast cancer.与乳腺癌放射性皮炎相关的预测因素。
Cancer Treat Res Commun. 2021;28:100403. doi: 10.1016/j.ctarc.2021.100403. Epub 2021 May 26.
9
How do patient-reported outcomes compare with clinician assessments? A prospective study of radiation dermatitis in breast cancer.患者报告结局与临床医生评估相比如何？乳腺癌放射性皮炎的前瞻性研究。
Radiother Oncol. 2021 Jun;159:98-105. doi: 10.1016/j.radonc.2021.03.020. Epub 2021 Mar 23.
10
Objective Evaluation of Risk Factors for Radiation Dermatitis in Whole-Breast Irradiation Using the Spectrophotometric L*a*b Color-Space.使用分光光度法L*a*b颜色空间客观评估全乳照射中放射性皮炎的风险因素。
Cancers (Basel). 2020 Aug 28;12(9):2444. doi: 10.3390/cancers12092444.
Zotero 插件